Responses
EULAR 2014: Scientific Abstracts
Poster Presentations. SLE, Sjögren's and APS - treatment
FRI0389 Effects of Chronic Treatment with Subcutaneous Blisibimod on Renal and Inflammation Biomarkers in Subjects with Systemic Lupus Erythematosus in Phase 2 PEARL-SC and Open-Label Extension Studies
Compose a Response to This Article
Other responses
No responses have been published for this article.